ZPHC Retatrutide 40mg kit 5 Vail

ZPHC Retatrutide 40mg Kit (5 Vials × 8mg) is a research-grade triple agonist compound targeting GLP-1, GIP, and glucagon receptors. Supplied as a lyophilized powder kit for laboratory investigation, this formulation is not approved for human consumption and is strictly intended for research purposes only.
ZPHC Retatrutide 40mg Kit represents a high-purity lyophilized peptide formulation designed for advanced metabolic research. Each kit contains five individual vials, each containing 8mg of Retatrutide, totaling 40mg per kit.
Retatrutide (LY3437943) is classified as a triple incretin receptor agonist, engaging the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously. In preclinical and clinical research settings, this multi-receptor mechanism has been associated with significant metabolic effects, including adipose tissue remodeling, enhanced lipid oxidation, and improvements in glucose homeostasis. Research indicates that Retatrutide may influence energy expenditure through glucagon receptor activation, differentiating its metabolic profile from dual agonists.

This ZPHC kit is manufactured under strict laboratory conditions to ensure peptide stability and purity. The lyophilized format allows for extended storage prior to reconstitution. Beast Muscle supplies this product exclusively to licensed researchers and institutions within Egypt for in vitro and preclinical investigation.

Technical Specifications:
Compound: Retatrutide (LY3437943)
Total Content: 40mg per kit
Vial Configuration: 5 vials × 8mg each
Form: Lyophilized powder
Storage: Store refrigerated (2–8°C) prior to reconstitution; protect from light.

Directions for Research Use
Allow vials and diluent to reach room temperature before mixing.
Using aseptic technique, slowly inject bacteriostatic water or sterile saline down the inner wall of the vial.
Gently swirl; do not shake vigorously, as this may denature the peptide.
Allow the solution to dissolve completely before use.

Storage After Reconstitution:
Store reconstituted solution refrigerated at 2–8°C.
For research integrity, use within a reasonable timeframe; peptide degradation may occur over extended periods.

Handling:
Use appropriate personal protective equipment (gloves, lab coat, eye protection).
This product is not for injection into humans or animals.

Warnings and Disclaimers
Not for Human Use: ZPHC Retatrutide is sold strictly as a research chemical. It is not a pharmaceutical product, dietary supplement, or approved medication. It must never be administered to humans.
Regulatory Status in Egypt: The Egyptian Drug Authority has confirmed that Retatrutide is not registered in Egypt and has issued warnings regarding unapproved products marketed under this name. Purchasing or possessing unregistered pharmaceutical substances may carry legal risks

Note About BEAST MUSCLE

We always strive to update product images on our store according to the versions available to us. There may be some changes in manufacturing, packaging, components, or external appearance from the producing companies. Shipments may carry an alternative shape or a newer version than shown in our store, but this does not reduce the guarantee of quality and originality of the products. We recommend that you read the warnings and instructions for each product before use and do not rely solely on the information provided by BEAST MUSCLE.